A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.

Autor: Mokhtare, Marjan1 (AUTHOR), Fathi, Maryam (AUTHOR), Sadeghian, Amir M. (AUTHOR), Sotoudeheian, Mohammad-Javad (AUTHOR), Namazi, Abolfazl (AUTHOR)
Zdroj: Clinical Drug Investigation. Oct2024, p1-9.
Databáze: Academic Search Ultimate
Externí odkaz: